Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00514293
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2007-08-08
Brief Title:
Bexarotene Tretinoin and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Raghu Nandan MD Inc
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000561066
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Raghu Nandan MD Inc
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Raghu Nandan
Old Organization:
R Nandan MD Incorporated